Roche investing an additional 1.2 billion Swiss francs in Basel Roche will be putting an additional 1.2 billion Swiss francs towards the renovation of its site in Basel. This investment…martin11.17.2023
Nouscom secures 67.5 million euros in financing Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use…martin11.14.2023
Paradigm shift in pain management Pain is a crucial sensation for survival, but it can also drive us to depression and long-term suffering if not…martin11.10.2023
Investors stump up 3.7 million Swiss francs in Onena Medicines Onena Medicines has secured an investment of 3.7 million Swiss francs. The portfolio company of the biotech startup incubator BaseLaunch…martin11.03.2023
CSL joins Basel Area biotech cluster The research and development department of the globally active Australian biotech company CSL has moved into a new office in…martin11.02.2023
Palto Therapeutics receives 150,000 Swiss francs from Venture Kick Allschwil-based Palto Therapeutics has won the third stage of the Venture Kick promotional funding program. As such, the company now…martin10.30.2023
Roche uses artificial intelligence for cancer diagnosis Roche is teaming up with Ibex Medical Analytics and Amazon Web Services in the field of artificial intelligence. The goal…martin10.26.2023
Cimeio collaborating with the University of Pennsylvania The Basel-based startup Cimeio has been offered an exceptional opportunity for a preclinical research collaboration with the University of Pennsylvania,…martin10.17.2023
biGENIUS receives 2 million euros for new cloud product Software company biGENIUS, based in the Basel Area, has secured financing of 2 million euros. This funding was granted following…martin10.03.2023
Opterion Health secures investment of 6.5 million Swiss francs Opterion Health has raised a total of 6.5 million Swiss francs as part of a financing round. The company, which…martin09.22.2023